Case Series:Acute Tumor Lysis Syndrome in Mutator Mice with Disseminated Lymphoblastic Lymphoma

Toxicologic Pathology

Volumn 38, Issue 3, 2010, Pages 476-485

  Treuting, Piper M ^a   Albertson, Tina M ^a   Preston, Bradley D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

acute tumor lysis syndrome; DNA polymerase; DNA replication; lymphoblastic lymphoma; mismatch repair; mutator

Indexed keywords

FIBRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER SUSCEPTIBILITY; CASE STUDY; CHROMATIN; CONTROLLED STUDY; DEATH; DNA REPLICATION; ELECTRON MICROSCOPY; ERYTHROCYTE; GENETIC DISORDER; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD VESSEL; LEUKEMIA; LUNG BLOOD VESSEL; LYMPHOBLASTOMA; MICROTHROMBUS; MORTALITY; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOEMBOLISM; TUMOR LYSIS SYNDROME; TUMOR VOLUME;

ANIMALS; DNA MISMATCH REPAIR; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROSCOPY, ELECTRON, TRANSMISSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; THROMBOEMBOLISM; TUMOR LYSIS SYNDROME;

ANIMALIA; MUS;

EID: 77952523879     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310362249     Document Type: Article

References (36)

1. Albertson T. M. Ogawa M. Bugni J. M. Hays L. E. Chen Y. Wang Y. Treuting P. M. Heddle J. A. Goldsby R. E. Preston B. D. (2009). DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice. Proc Natl Acad Sci U S A 106, 17100–03.
2. Bosly A. Sonet A. Pinkerton C. R. McCowage G. Bron D. Sanz M. A. Van den Berg H. (2003). Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer 98, 1048–54.
3. Calia C. M. Hohenhaus A. E. Fox P. R. Meleo K. A. (1996). Acute tumor lysis syndrome in a cat with lymphoma. J Vet Intern Med 10, 409–11.
4. Coiffier B. Altman A. Pui C. H. Younes A. Cairo M. S. (2008). Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26, 2767–78.
5. Davidson M. B. Thakkar S. Hix J. K. Bhandarkar N. D. Wong A. Schreiber M. J. (2004). Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116, 546–54.
6. Duzova A. Cetin M. Gumruk F. Yetgin S. (2001). Acute tumour lysis syndrome following a single-dose corticosteroid in children with acute lymphoblastic leukaemia. Eur J Haematol 66, 404–7.
7. Eckman L. N. Lynch E. C. (1978). Acute renal failure in patients with acute leukemia. South Med J 71, 382–85.
8. Edelmann L. Edelmann W. (2004). Loss of DNA mismatch repair function and cancer predisposition in the mouse: Animal models for human hereditary nonpolyposis colorectal cancer. Am J Med Genet C Semin Med Genet 129C, 91–99.
9. Edelmann W. Yang K. Kuraguchi M. Heyer J. Lia M. Kneitz B. Fan K. Brown A. M. Lipkin M. Kucherlapati R. (1999). Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Cancer Res 59, 1301–7.
10. Frith C. H. Ward J. M. Harleman J. H. Stromberg P. C. Halm S. Inoue T. Wright J. A. (2001). Hematopoietic system. In International Classification of Rodent Tumors: The Mouse (Mohr U., ed.), pp. 418–20. Springer-Verlag, Berlin.
11. Goldsby R. E. Hays L. E. Chen X. Olmsted E. A. Slayton W. B. Spangrude G. J. Preston B. D. (2002). High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading. Proc Natl Acad Sci U S A 99, 15560–65.
12. Hochberg J. Cairo M. S. (2008). Tumor lysis syndrome: Current perspective. Haematologica 93, 9–13.
13. Jacoby R. O. Fox J. G. (2002). Biology and diseases of mice. In Laboratory Animal Medicine (Fox J. G. Anderson L. C., eds.), p. 43. Academic Press, San Diego.
14. Jeha S. Pui C. H. (2005). Recombinant urate oxidase (rasburicase) in the prophylaxis and treatment of tumor lysis syndrome. Contrib Nephrol 147, 69–79.
15. LaCarrubba A. M. Johnson P. J. Whitney M. S. Miller M. A. Lattimer J. C. (2006). Hypoglycemia and tumor lysis syndrome associated with peritoneal mesothelioma in a horse. J Vet Intern Med 20, 1018–22.
16. Laing E. J. Carter R. F. (1988). Acute tumor lysis syndrome following treatment of canine lymphoma. J Am Anim Hosp Assoc 24, 6.
17. Levi M. (2009). Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol 22, 129–36.
18. Lin D. P. Wang Y. Scherer S. J. Clark A. B. Yang K. Avdievich E. Jin B. Werling U. Parris T. Kurihara N. Umar A. Kucherlapati R. Lipkin M. Kunkel T. A. Edelmann W. (2004). An Msh2 point mutation uncouples DNA mismatch repair and apoptosis. Cancer Res 64, 517–22.
19. Lovelace K. vanGessel Y. Asher L. V. Vogel P. (2003). Spontaneous acute tumor lysis syndrome in a DBA/1J mouse: A case report and review. Toxicol Pathol 31, 486–90.
20. Lundberg W. B. Cadman E. D. Finch S. C. Capizzi R. L. (1977). Renal failure secondary to leukemic infiltration of the kidneys. Am J Med 62, 636–42.
21. Morse H. C. 3rd Anver M. R. Fredrickson T. N. Haines D. C. Harris A. W. Harris N. L. Jaffe E. S. Kogan S. C. MacLennan I. C. Pattengale P. K. Ward J. M. (2002). Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100, 246–58.
22. Mukherjee E. Mukherji D. Jayawardene S. A. Kon S. P. (2007). Tumor lysis syndrome and acute renal failure—an increasing spectrum of presentations. Clin Nephrol 68, 186–89.
23. Mylonakis M. E. Koutinas A. F. Papaioannou N. Lekkas S. (2007). Acute tumour lysis syndrome in a dog with B-cell multicentric lymphoma. Aust Vet J 85, 206–8.
24. Norris H. J. Wiener J. (1961). The renal lesions in leukemia. Am J Med Sci 241, 512–18.
25. Olgar S. Yetgin S. Cetin M. Aras T. Akhan O. (2005). Electrolyte abnormalities at diagnosis of acute lymphocytic leukemia may be a clue for renal damage in long-term period. J Pediatr Hematol Oncol 27, 202–6.
26. Page R. L. (1986). Acute tumor lysis syndrome. Semin Vet Med Surg (Small Anim) 1, 58–60.
27. Patte C. Sakiroglu O. Sommelet D. (2001). European experience in the treatment of hyperuricemia. Semin Hematol 38, 9–12.
28. Pui C. H. Mahmoud H. H. Wiley J. M. Woods G. M. Leverger G. Camitta B. Hastings C. Blaney S. M. Relling M. V. Reaman G. H. (2001). Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 19, 697–704.
29. Radaelli E. Marchesi F. Patton V. Scanziani E. (2009). Diagnostic exercise: sudden death in a mouse with experimentally induced acute myeloid leukemia. Vet Pathol 46, 1301–5.
30. Smits R. Hofland N. Edelmann W. Geugien M. Jagmohan-Changur S. Albuquerque C. Breukel C. Kucherlapati R. Kielman M. F. Fodde R. (2000). Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity. Genes Chromosomes Cancer 29, 229–39.
31. ten Cate H. Falanga A. (2008). Overview of the postulated mechanisms linking cancer and thrombosis. Pathophysiol Haemost Thromb 36, 122–30.
32. Tosi P. Barosi G. Lazzaro C. Liso V. Marchetti M. Morra E. Pession A. Rosti G. Santoro A. Zinzani P. L. Tura S. (2008). Consensus conference on the management of tumor lysis syndrome. Haematologica 93, 1877–85.
33. Venkatesan R. N. Treuting P. M. Fuller E. D. Goldsby R. E. Norwood T. H. Gooley T. A. Ladiges W. C. Preston B. D. Loeb L. A. (2007). Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Mol Cell Biol 27, 7669–82.
34. Vickery K. R. Thamm D. H. (2007). Successful treatment of acute tumor lysis syndrome in a dog with multicentric lymphoma. J Vet Intern Med 21, 1401–4.
35. Ward J. M. Mann P. C. Morishima H. Frith C. H. (1999). Thymus, spleen, and lymph nodes. In Pathology of the Mouse (Maronpot R. R., ed.), p. 335. Cache River Press, Vienna, IL.
36. Wu X. W. Lee C. C. Muzny D. M. Caskey C. T. (1989). Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci U S A 86, 9412–16.